Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
ARPA-H-SOL-25-122 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) solicitation, performed in Washington, DC, with responses due 2026-02-05. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Amendment 7: Changes to the ISO The purpose of this amendment is to amend the THRIVE ISO. An updated version of the ISO, with changes in red font, is included as an attachment to this amendment. Changes to the ISO include: Clarified the inclusion and application of indirect rates as part of the enco
Comparable recent awards in RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
| Winner | Award value | Offers | Date |
|---|---|---|---|
| AMERICAN TYPE CULTURE COLLECTION | $4.3M | n/a | 2026-07-01 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | $17.5M | n/a | 2026-06-30 |
| MICRON BIOMEDICAL INC | $4.5M | 18 | 2026-06-24 |
| TWIST BIOSCIENCE CORPORATION | $47K | 1 | 2026-06-24 |
| CHROMOLOGIC LLC | $4.5M | 18 | 2026-06-24 |
Questions
What is solicitation ARPA-H-SOL-25-122?
Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE), issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 541714 (RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)), performed in Washington, DC. Responses are due 2026-02-05.
What do similar contracts close for?
Comparable closed awards in this category ran from $47K to $17.5M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is ARPA-H-SOL-25-122 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.